Time-resolved immunofluorometric dual-label assay for simultaneous detection of autoantibodies to GAD65 and IA-2 in children with type I diabetes

Clinical Chemistry

Volumn 53, Issue 3, 2007, Pages 472-479

  Ankelo, Matti ^a,b,c   Westerlund, Annette ^a,b   Blomberg, Kaj ^c   Knip, Mikael ^a,d,e   Ilonen, Jorma ^a,f   Hinkkanen, Ari E ^a,b  

^a Juvenile Diabetes Research Foundation International   (United States)

^b ÅBO AKADEMI UNIVERSITY   (Finland)

^c PerkinElmer Finland Oy   (Finland)

^d UNIVERSITY OF HELSINKI   (Finland)

^e TAMPERE UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF TURKU   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; GLUTATHIONE TRANSFERASE 1A 2 ANTIBODY; GLUTATHIONE TRANSFERASE A1; STREPTAVIDIN; UNCLASSIFIED DRUG;

ADOLESCENT; ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; ENZYME ASSAY; FEMALE; HUMAN; IMMUNOFLUORESCENCE TEST; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; SCHOOL CHILD; SCREENING;

ADOLESCENT; AUTOANTIBODIES; CHILD; DIABETES MELLITUS, TYPE 1; FEMALE; FLUOROIMMUNOASSAY; GLUTAMATE DECARBOXYLASE; HUMANS; ISOENZYMES; MALE; RADIOLIGAND ASSAY; SENSITIVITY AND SPECIFICITY;

EID: 33947358184     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1373/clinchem.2005.064568     Document Type: Article

References (17)

1. Verge CF, Gianani R, Kawasaki E, Yu L, Pietropaolo M, Chase HP, et al. Number of autoantibodies (against insulin, GAD or ICA512/ IA2) rather than particular autoantibody specificities determines risk of type I diabetes. J Autoimmun 1996;9:379-83.
2. Decochez K, De Leeuw IH, Keymeulen B, Mathieu C, Rottiers R, Weets I, et al. IA-2 autoantibodies predict impending type I diabetes in siblings of patients. Diabetologia 2002;45:1658-66.
3. Zimmet P, Turner R, McCarty D, Rowley M, Mackay I. Crucial points at diagnosis: type 2 diabetes or slow type 1 diabetes. Diabetes Care 1999;22(Suppl. 2):B59-64.
4. Lohmann T, Kellner K, Verlohren H-J, Krug J, Steindorf J, Scherbaum WA, et al. Titre and combination of ICA and autoantibodies to glutamic acid decarboxylase discriminate two clinically distinct types of latent autoimmune diabetes in adults (LADA). Diabetologia 2001;44:1005-10.
5. Grubin CE, Daniels T, Toivola B, Landin-Olsson M, Hagopian WA, Li L, et al. A novel radioligand binding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM. Diabetologia 1994;37:344-50.
6. Petersen JS, Hejnæs KR, Moody A, Karlsen AE, Marshall MO, Høier-Madsen M, et al. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes 1994;43:459-67.
7. Savola K, Bonifacio E, Sabbah E, Kulmala P, Vähäsalo P, Karjalainen J, et al. IA-2 antibodies: a sensitive marker of IDDM with clinical onset in childhood and adolescence. Childhood Diabetes in Finland Study Group. Diabetologia 1998;41:424-9.
8. Savola K, Sabbah E, Kulmala P, Vähäsalo P, Ilonen J, Knip M. Autoantibodies associated with Type I diabetes mellitus persist after diagnosis in children. Diabetologia 1998;41:1293-7.
9. Dittler J, Seidel D, Schenker M, Ziegler AG. GADIA2-combi determination as first-line screening for improved prediction of type 1 diabetes in relatives. Diabetes 1998;47:592-7.
10. Zavialov A, Ankelo M, Westerlund-Karlsson A, Knip M, Ilonen J, Hinkkanen A. Novel fusion proteins in the analysis of diabetes-associated autoantibodies to GAD65 and IA-2. J Immunol Methods 2000;246:91-6.
11. Rickert M, Seissler J, Dangel W, Lorenz H, Richter W. Fusion proteins for combined analysis of autoantibodies to the 65-kDa isoform of glutamic acid decarboxylase and islet antigen-2 in insulin-dependent diabetes mellitus. Clin Chem 2001;47:926-34.
12. Ankelo M, Westerlund-Karlsson A, Ilonen J, Knip M, Savola K, Kankaanpää P, et al. Time-resolved fluorometric assay for detection of autoantibodies to glutamic acid decarboxylase (GAD65). Clin Chem 2003;49:908-15.
13. Westerlund-Karlsson A, Suonpää K, Ankelo M, Ilonen J, Knip M, Hinkkanen AE. Detection of autoantibodies to protein tyrosine phosphatase-like protein IA-2 with a novel time-resolved fluorimetric assay. Clin Chem 2003;49:916-23.
14. Kulmala P, Savola K, Reijonen H, Veijola R, Vähäsalo P, Karjalainen J, et al. Genetic markers, humoral autoimmunity, and prediction of type 1 diabetes in siblings of affected children. Diabetes 2000;101:48-58.
15. Barker JM, Goehrig SH, Barriga K, Hoffman M, Slover R, Eisenbarth GS, et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 2004;27:1399-404.
16. Sabbah E, Savola K, Ebeling T, Kulmala P, Vahasalo P, Ilonen J, et al. Genetic, autoimmune, and clinical characteristics of childhood-and adult-onset type 1 diabetes. Diabetes Care 2000;23:1326-32.
17. Pihoker C, Gilliam LK, Hampe CS, Lemmark A. Autoantibodies in diabetes [Review]. Diabetes. 2005;54(Suppl 2):S52-61.